Glimicut MV1 Tablet 10 is used to manage type 2 diabetes mellitus in adults whose blood sugar levels are not adequately controlled by a single medicine. It is a combination medicine containing glimepiride, voglibose and metformin as active ingredients.
Glimepiride stimulates the pancreas to release more insulin, while metformin improves the body's sensitivity to insulin and reduces glucose production in the liver. Voglibose works by delaying the digestion of complex carbohydrates, thereby preventing sharp rises in blood sugar after meals. This helps maintain healthy glucose levels, which is crucial for preventing long-term complications like kidney damage, nerve problems and vision loss.
The treatment is most effective when combined with a structured diet and regular physical activity as prescribed by your doctor. Consult your doctor about regular blood sugar monitoring and the risk of hypoglycaemia before starting this medicine.






















































